Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer cachexia and immunomodulation.

P M Myrianthefs1, C Batistaki

  • 1Athens University School of Nursing, ICU at "KAT" Hospital, Athens, Greece.

Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology
|March 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of sugammadex versus neostigmine/atropine combination on postoperative cognitive dysfunction after elective surgery.

Anaesthesia and intensive care·2017
Same author

The Greek version of Shoulder Pain and Disability Index (SPADI): translation, cultural adaptation, and validation in patients with rotator cuff tear.

Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology·2016
Same author

General anaesthesia in a recent heart transplant recipient for endovascular aortic aneurysm repair.

Anaesthesia and intensive care·2013
Same author

Sugammadex to reverse rocuronium and facilitate intraoperative motor evoked potentials monitoring during spinal surgery.

Anaesthesia and intensive care·2012
Same author

Sugammadex antagonising rocuronium in three patients with liver dysfunction undergoing transjugular intrahepatic portosystemic shunt.

Anaesthesia and intensive care·2012
Same author

Monotherapy with inhaled colistin for the treatment of patients with ventilator-associated tracheobronchitis due to polymyxin-only-susceptible Gram-negative bacteria.

The Journal of hospital infection·2011
Same journal

Vitamin C through upregulating SYNPO2 level suppresses the proliferation and migration of glioma cells.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2021
Same journal

Some concerns about clinical-pathological characteristics of breast cancer cases detected by chest computed tomography.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2021
Same journal

SARS-CoV-2 infection in breast carcinoma patients.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2021
Same journal

Preference of trastuzumab emtansine as a second or third line treatment in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer refractory to trastuzumab and pertuzumab.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2021
Same journal

Taxane use for breast cancer-related lymphoedema risk.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2021
Same journal

The place of Omalizumab in the treatment of Carboplatin hypersensitivity.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology·2021
See all related articles

Cachexia, a severe weight loss condition, is driven by cancer and immune dysfunction. Understanding these links guides immunomodulatory strategies to potentially reverse cachexia and restore immune function.

Area of Science:

  • Oncology
  • Immunology
  • Metabolic Disorders

Background:

  • Cachexia is a debilitating condition characterized by involuntary weight loss, often complicating malignant, infectious, and inflammatory diseases.
  • Its etiology is multifactorial, involving cytokines, hormones, neuropeptides, neurotransmitters, and tumor-derived factors, leading to lipolysis and protein degradation.
  • Cancer cachexia is closely linked with immune dysfunction, suggesting a bidirectional relationship where the tumor impacts immunity and cachexia is mediated by immune responses.

Purpose of the Study:

  • To explore the mechanisms underlying cancer cachexia and associated immune dysfunction.
  • To evaluate the potential of immunomodulatory strategies in reversing cachexia and immune deficiencies in cancer patients.
  • To highlight the need for further experimental and clinical research on these interventions.

Related Experiment Videos

Main Methods:

  • Review of existing hypotheses on cachexia etiology, including cytokine involvement and tumor products.
  • Analysis of various management strategies applied to cachexia and immunodeficiency.
  • Discussion of the conceptual framework linking tumor, cachexia, and immune dysfunction.

Main Results:

  • Cachexia is predominantly caused by cytokines and tumor products that induce significant lipolysis and protein breakdown.
  • A wide range of therapeutic strategies have been employed, from nutritional support to pharmacological agents and emerging drugs.
  • The interplay between cancer, cachexia, and immune dysfunction suggests that targeting both the tumor and immune pathways is crucial.

Conclusions:

  • Restoring immune efficiency by targeting tumor-related cachexia and immune pathways is a promising therapeutic approach.
  • Further experimental and clinical studies are essential to validate the efficacy of immunomodulatory interventions in cancer cachexia.
  • A deeper understanding of the mechanisms driving cancer cachexia is key to developing effective treatments.